Holly Hagan

Professor of Social and Behavioral Sciences

Professional overview

Dr. Holly Hagan is a Professor in the Departments of Social Behavioral Sciences and Epidemiology at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders.  Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.

Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY. 

Education

PhD Epidemiology, University of Washington, Seattle, WA

MPH Epidemiology, University of Massachusetts, Amherst, MA

BA Russian Studies, Evergreen State College, Olympia, WA

Publications

Publications

Predictors of accidental fatal drug overdose among a cohort of injection drug users

Public health and changes in illicit drug prices

Sharing of drug preparation equipment as a risk factor for hepatitis C

Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users

Changes in injection risk behavior associated with participation in the Seattle needle-exchange program

HIV and HCV infection among injecting drug users

Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

Re: 'Syringe exchange and risk of infection with hepatitis B and C viruses' [2] (multiple letters)

Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors

Volunteer bias in nonrandomized evaluations of the efficacy of needle- exchange programs

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial

Syringe exchange and risk of infection with hepatitis B and C viruses

Hepatitis C virus transmission dynamics in injection drug users

HIV among injecting drug users

Drug use

Emerging infectious diseases and the injection of illicit psychoactive substances

Des Jarlais, D. C., Stimson, G. V., Hagan, H., Perlman, D., Choopanya, K., Bastos, F., & Friedman, S. (n.d.).

Publication year

1996

Journal title

Current Issues in Public Health

Volume

2

Page(s)

130-137

HIV among injecting drug users

Des Jarlais, D. C., Hagan, H., & Friedman, S. (n.d.). In J. Lowinson, P. Ruiz, R. Millman, & J. Langrod (Eds.), Substance abuse: Epidemiology and emerging public health perspectives (3rd eds., 1–).

Publication year

1996

Injection drug use and emerging blood-borne diseases [2]

Des Jarlais, D. C., Stimson, G. V., Hagan, H., & Friedman, S. R. (n.d.). In JAMA (1–).

Publication year

1996

Volume

276

Issue

13

Page(s)

1034

10.1001/jama.1996.03540130032014

The protective effect of AIDS-related behavioral change among injection drug users: A cross-national study

Maintaining low HIV seroprevalence in populations of injecting drug users

Management of children with hypodermic needle injuries

Bell, T., & Hagan, H. (n.d.).

Publication year

1995

Journal title

The Pediatric Infectious Disease Journal

Volume

14

Issue

3

Page(s)

254-255

Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program

An interview study of participants in the Tacoma, Washington, syringe exchange

Studies of HIV/AIDS and injecting drug use

Des Jarlais, D. C., Friedman, S. R., & Hagan, H. (n.d.).

Publication year

1992

Journal title

AIDS Care

Volume

4

Issue

4

Page(s)

481-485

10.1080/09540129208253129

The Incidence of HBV Infection and Syringe Exchange Programs